IP Verse

Tert Promoter Mutations In Gliomas And A Subset Of Tumors

EP3360979

DUKE UNIVERSITY
Application Number
EP18164632A
Filing Date
Feb 18, 2014
Status
Revoked
Dec 9, 2022
Grant Date
May 20, 2020
External Links
Slate, Register

Biblio Summary

The patent EP3360979B1 was granted on May 20, 2020 by Duke University The patent is currently Revoked.

Oppositions Filed by other Companies on the Patent

The table below shows 1 patent oppositions filed on the patent at EPO, listing each opposing company and filing date. Tracking these filings indicates that the applicant is active in this industry, while opposing companies may be signaling their own interest in competing within the same space. These disputes are essential for insights into competitor actions, patent strategy and emerging technological trends.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

BUHLER, DIRKFeb 22, 2021ADMISSIBLE

More Opposed Patents of Duke University

The table below shows the patents of Duke University that have been opposed by other companies.

Patent NumberTitleGrant DateOpposition Count
EP3823992Anti-Lypd3 Car T-Cell Therapy For The Treatment Of CancerDec 13, 20231
EP3773486Methods Of Treating Autism Spectrum Disorders Using Human Umbilical Cord Tissue-Derived Mesenchymal Stromal CellsDec 6, 20231
EP3122426Method Of Treating Cancer Using Selective Estrogen Receptor ModulatorsJan 18, 20232

Dossier Documents of the Patent

The documents dossier of the patent at EPO including all essential records in the patent's lifecycle, from filing to grant to oppositions.

  • Date

    Description

  • Get instant alerts for new documents